share_log

騰盛博藥-B：董事會召開日期

BRII-B: DATE OF BOARD MEETING

香港交易所 ·  Mar 11 04:39
Summary by Moomoo AI
腾盛博药生物科技有限公司（「本公司」）宣布，將於2024年3月22日（星期五）召開董事會會議，主要目的是審閱及批准發佈截至2023年12月31日止年度的全年業績。會議將由董事會主席Zhi Hong博士主持，並將處理其他事項。董事會成員包括執行董事Zhi Hong博士及李安康博士，非執行董事Robert Taylor Nelsen先生，以及獨立非執行董事Martin J Murphy Jr博士、Grace Hui Tang女士、徐耀華先生、Gregg Huber Alton先生及楊台瑩博士。
腾盛博药生物科技有限公司（「本公司」）宣布，將於2024年3月22日（星期五）召開董事會會議，主要目的是審閱及批准發佈截至2023年12月31日止年度的全年業績。會議將由董事會主席Zhi Hong博士主持，並將處理其他事項。董事會成員包括執行董事Zhi Hong博士及李安康博士，非執行董事Robert Taylor Nelsen先生，以及獨立非執行董事Martin J Murphy Jr博士、Grace Hui Tang女士、徐耀華先生、Gregg Huber Alton先生及楊台瑩博士。
Tengsheng Bo Pharmaceutical Biotechnology Co., Ltd. (the “Company”) announces that a Board Meeting will be held on Friday, March 22, 2024, for the primary purpose of reviewing and approving the release of the annual results for the year ended December 31, 2023. The meeting will be chaired by Dr. Zhi Hong, Chairman of the Board, and will deal with other matters. Board members include Executive Directors Dr. Zhi Hong and Dr. Li An Kang, Non-Executive Director Mr. Robert Taylor Nelsen, and Independent Non-Executive Directors Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Xu Yiu Wah, Mr. Gregg Huber Alton and Dr. Yang Taiying.
Tengsheng Bo Pharmaceutical Biotechnology Co., Ltd. (the “Company”) announces that a Board Meeting will be held on Friday, March 22, 2024, for the primary purpose of reviewing and approving the release of the annual results for the year ended December 31, 2023. The meeting will be chaired by Dr. Zhi Hong, Chairman of the Board, and will deal with other matters. Board members include Executive Directors Dr. Zhi Hong and Dr. Li An Kang, Non-Executive Director Mr. Robert Taylor Nelsen, and Independent Non-Executive Directors Dr. Martin J Murphy Jr, Ms. Grace Hui Tang, Mr. Xu Yiu Wah, Mr. Gregg Huber Alton and Dr. Yang Taiying.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more